We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Erik Justin Shank is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2004 — 2006 |
Shank, Erik J |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Role of Cb1 Receptors in Cannabinoid-Induced Behavior @ University of Texas Medical Br Galveston
[unreadable] DESCRIPTION (provided by applicant): [unreadable] Marijuana is undoubtedly the most abused illicit drug in the world. The active ingredient in marijuana is delta-9-tetrahydrocannabinol, a member of the cannabinoid family for which there are two known receptors: CB1 (primarily CNS) and CB2 receptors. We will test the hypothesis that intra-VTA CB1 receptor activation with the synthetic agonist CP55, 940 can induce hyperactivity and that these receptors are located on GABA neurons within the VTA. Furthermore, we will test the hypothesis that normal GABA function is necessary for the behavioral effects of intra-VTA CP55, 940 infusion by selectively lesioning the GABA neurons within the VTA followed by subsequent CB1 agonist administration. The observation that acute microinfusion of the cannabinoid agonist CP55, 940 into the reward pathway results in hyperactivity would support the hypothesis that cannabinoids utilize similar circuitry as other abused drugs (e.g., cocaine, amphetamines, heroin, etc.) and suggest that the systemic effects of cannabinoids are a composite of actions in the mesoaccumbens and other pathways. These data are, therefore, critical in elucidating the rewarding/reinforcing effects of cannabinoid agonists. [unreadable] [unreadable] [unreadable] [unreadable]
|
0.92 |